D. Tabak

418 total citations
22 papers, 366 citations indexed

About

D. Tabak is a scholar working on Organic Chemistry, Oncology and Molecular Biology. According to data from OpenAlex, D. Tabak has authored 22 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Organic Chemistry, 8 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in D. Tabak's work include Metal complexes synthesis and properties (8 papers), Synthesis and biological activity (4 papers) and HIV/AIDS drug development and treatment (4 papers). D. Tabak is often cited by papers focused on Metal complexes synthesis and properties (8 papers), Synthesis and biological activity (4 papers) and HIV/AIDS drug development and treatment (4 papers). D. Tabak collaborates with scholars based in Poland, Slovakia and Czechia. D. Tabak's co-authors include Robert Musioł, Jarosław Polański, Halina Niedbala, Barbara Podeszwa, Jacek Finster, B. Machura, Jiřı́ Dohnal, Joachim Kusz, Josef Jampílek and R. Kruszyński and has published in prestigious journals such as Molecules, Journal of Organometallic Chemistry and Bioorganic & Medicinal Chemistry.

In The Last Decade

D. Tabak

22 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Tabak Poland 12 254 100 80 37 36 22 366
Katsuji Aikawa Japan 11 257 1.0× 159 1.6× 91 1.1× 30 0.8× 14 0.4× 13 488
Farag A. El‐Essawy Egypt 14 373 1.5× 113 1.1× 80 1.0× 50 1.4× 12 0.3× 43 527
Jacek Finster Poland 9 385 1.5× 151 1.5× 51 0.6× 20 0.5× 56 1.6× 14 487
Yuichi Sugano Japan 11 509 2.0× 184 1.8× 89 1.1× 28 0.8× 23 0.6× 22 641
Nalan Terzioğlu Türkiye 9 525 2.1× 140 1.4× 82 1.0× 23 0.6× 26 0.7× 14 643
S. Bergemann Germany 10 239 0.9× 93 0.9× 174 2.2× 31 0.8× 11 0.3× 16 385
Srinivas K. Kumar United States 7 289 1.1× 207 2.1× 101 1.3× 25 0.7× 16 0.4× 9 493
Muammer Kiraz Türkiye 11 771 3.0× 131 1.3× 118 1.5× 41 1.1× 24 0.7× 19 851
Salwa F. Mohamed Egypt 12 693 2.7× 147 1.5× 43 0.5× 19 0.5× 33 0.9× 31 769
Sau Hing Chan Hong Kong 8 385 1.5× 152 1.5× 60 0.8× 20 0.5× 20 0.6× 8 500

Countries citing papers authored by D. Tabak

Since Specialization
Citations

This map shows the geographic impact of D. Tabak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Tabak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Tabak more than expected).

Fields of papers citing papers by D. Tabak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Tabak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Tabak. The network helps show where D. Tabak may publish in the future.

Co-authorship network of co-authors of D. Tabak

This figure shows the co-authorship network connecting the top 25 collaborators of D. Tabak. A scholar is included among the top collaborators of D. Tabak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Tabak. D. Tabak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cieślik, Wioleta, Katarzyna Malarz, D. Tabak, et al.. (2015). Investigation of the Antimycobacterial Activity of 8-Hydroxyquinolines. Medicinal Chemistry. 11(8). 771–779. 10 indexed citations
2.
Machura, B., Mariusz Wolff, D. Tabak, Jörg A. Schachner, & Nadia C. Mösch‐Zanetti. (2012). Oxidorhenium(V) Complexes with Phenolate‐ and Carboxylate‐Based Ligands: Structure and Catalytic Epoxidation. European Journal of Inorganic Chemistry. 2012(23). 3764–3773. 23 indexed citations
3.
Machura, B., Mariusz Wolff, D. Tabak, Yasuhisa Ikeda, & Kenji Hasegawa. (2012). Novel trans-dioxorhenium complex with imidazo[1,2a]pyridine ligand – Synthesis, spectroscopic and electrochemical characterization, X-ray crystal structure and DFT calculations. Polyhedron. 39(1). 76–84. 5 indexed citations
4.
Musioł, Robert, et al.. (2011). X-ray and molecular modelling in fragment-based design of three small quinoline scaffolds for HIV integrase inhibitors. Bioorganic & Medicinal Chemistry. 19(5). 1606–1612. 13 indexed citations
5.
Machura, B., Anna Świtlicka, Mariusz Wolff, et al.. (2010). Novel tricarbonyl rhenium complexes of 5,8-quinolinedione derivatives – Synthesis, spectroscopic characterisation, X-ray structure and DFT calculations. Journal of Organometallic Chemistry. 696(3). 731–738. 9 indexed citations
6.
Machura, B., Anna Świtlicka, J. Mroziński, et al.. (2009). Synthesis, spectroscopic characterization, X-ray structure and magnetic properties of [Cu(hmquin-7-COOH)2(MeOH)] complex. Polyhedron. 28(17). 3774–3780. 2 indexed citations
7.
Musioł, Robert, Josef Jampílek, Barbara Podeszwa, et al.. (2009). RP-HPLC determination of lipophilicity in series of quinoline derivatives. Open Chemistry. 7(3). 586–597. 15 indexed citations
9.
Jampílek, Josef, Robert Musioł, Matúš Peško, et al.. (2009). Ring-substituted 4-Hydroxy-1H-quinolin-2-ones: Preparation and Biological Activity. Molecules. 14(3). 1145–1159. 51 indexed citations
10.
Musioł, Robert, D. Tabak, Halina Niedbala, et al.. (2008). Investigating biological activity spectrum for novel quinoline analogues 2: Hydroxyquinolinecarboxamides with photosynthesis-inhibiting activity. Bioorganic & Medicinal Chemistry. 16(8). 4490–4499. 49 indexed citations
11.
Małecki, J.G., Joachim Kusz, R. Kruszyński, D. Tabak, & Z. Mazurak. (2008). The reaction between [RuCl2(PPh3)3] and hydroxyquinoline carboxylic acid. Structural Chemistry. 19(2). 257–263. 5 indexed citations
12.
Machura, B., Joachim Kusz, & D. Tabak. (2008). Synthesis, spectroscopic characterization, X-ray structure, and DFT calculations of [ReOBr2(hmquin-7-COOH)(AsPh3)]. Structural Chemistry. 20(3). 361–368. 4 indexed citations
13.
Podeszwa, Barbara, Halina Niedbala, Jarosław Polański, et al.. (2007). Investigating the antiproliferative activity of quinoline-5,8-diones and styrylquinolinecarboxylic acids on tumor cell lines. Bioorganic & Medicinal Chemistry Letters. 17(22). 6138–6141. 51 indexed citations
14.
Małecki, J.G., R. Kruszyński, D. Tabak, & Joachim Kusz. (2007). The reactions between [RuHCl(CO)(PPh3)3] and quinoline carboxylic acids. Polyhedron. 26(17). 5120–5130. 13 indexed citations
15.
Musioł, Robert, Jarosław Polański, Jiřı́ Dohnal, et al.. (2007). Preparation and Herbicidal Activities of Substituted Amides of Quinoline Derivatives. 1308–1308. 1 indexed citations
16.
Polański, Jarosław, Halina Niedbala, Robert Musioł, et al.. (2007). Fragment Based Approach for the Investigation of HIV-1 Integrase Inhibition. Letters in Drug Design & Discovery. 4(2). 99–105. 30 indexed citations
17.
Niedbala, Halina, Jarosław Polański, Rafał Gieleciak, et al.. (2006). Comparative Molecular Surface Analysis (CoMSA) for Virtual Combinatorial Library Screening of Styrylquinoline HIV-1 Blocking Agents. Combinatorial Chemistry & High Throughput Screening. 9(10). 753–770. 14 indexed citations
18.
Musioł, Robert, Josef Jampílek, Katarína Kráľová, et al.. (2006). Substituted Amides of Quinoline Derivatives: Preparation and Their Photosynthesis-inhibiting Activity. 1421–1421. 2 indexed citations
19.
Polański, Jarosław, Halina Niedbala, Robert Musioł, et al.. (2006). 5-Hydroxy-6-Quinaldic Acid as a Novel Molecular Scaffold for HIV-1 Integrase Inhibitors. Letters in Drug Design & Discovery. 3(3). 175–178. 32 indexed citations
20.
Polański, Jarosław, Halina Niedbala, Robert Musioł, et al.. (2004). Analogues of the styrylquinoline and styrylquinazoline HIV-1 integrase inhibitors: design and synthetic problems.. PubMed. 61 Suppl. 3–4. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026